MedTrace Logo

Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach

NCT02393885 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-12-19

Study results available
· View outcomes & findings →

Summary

The objective of this study is to establish the safety and effectiveness of a dual epicardial and endocardial ablation procedure for patients presenting with Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation

Conditions

Interventions

DEVICE

AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation

Sponsors & Collaborators

  • AtriCure, Inc.

    lead INDUSTRY

Principal Investigators

  • Kenneth Ellenbogen, MD · VCU

  • Vigneshwar Kasirajan, MD · VCU

  • Ali Khoynezhad, MD · MemorialCare Long Beach Medical Ctr

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2022-03-28
Completion
2024-04-17
FDA Device
Yes

Countries

  • United States
  • Belgium
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02393885 on ClinicalTrials.gov